September 15, 2025 · Form 4 insider transaction
Rangwala Reshma sold 408 shares of KARYOPHARM THERAPEUTICS INC at $6.43 per share, a transaction worth $2.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.